Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction

References

• Amani H, Habibey R, Hajmiresmail SJ, Latifi S, Pazoki-Toroudi H, Akhavan O. Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. J Mater Chem B. 2017;5:9452–9476. doi:10.1039/C7TB01689A
   PubMed Web of Science ®Google Scholar
• Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376:2053–2064. doi:10.1056/NEJMra1606915
   PubMed Web of Science ®Google Scholar
• Cabello JB, Burls A, Emparanza JI, Bayliss SE, Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev. 2016;12:CD007160.
   PubMedGoogle Scholar
• Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197–210. doi:10.1016/S0140-6736(16)30677-8
   PubMed Web of Science ®Google Scholar
• Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 2010;72:19–44. doi:10.1146/annurev.physiol.010908.163111
   PubMed Web of Science ®Google Scholar
• Chen WW, Gao RL, Liu LS, et al. China cardiovascular diseases report 2015: a summary. J Geriatr Cardiol. 2017;14:1–10.
   PubMedGoogle Scholar
• Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7:e30733. doi:10.1371/journal.pone.0030733
   PubMed Web of Science ®Google Scholar
• Garikipati VNS, Verma SK, Cheng Z, et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis. Nat Commun. 2019;10:4317. doi:10.1038/s41467-019-11777-7
   PubMed Web of Science ®Google Scholar
• Huang S, Li X, Zheng H, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857–2876. doi:10.1161/CIRCULATIONAHA.118.038361
   PubMed Web of Science ®Google Scholar
• Zhang S, Liao K, Miao Z, et al. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. Neuro Oncol. 2019;21:1284–1296. doi:10.1093/neuonc/noz128
   PubMed Web of Science ®Google Scholar
• Xiang T, Jiang HS, Zhang BT, Liu G. CircFOXO3 functions as a molecular sponge for miR-143-3p to promote the progression of gastric carcinoma via upregulating USP44. Gene. 2020;753:144798. doi:10.1016/j.gene.2020.144798
   PubMed Web of Science ®Google Scholar
• Lin SP, Hu J, Wei JX, et al. Silencing of circFoxO3 protects HT22 cells from glutamate-induced oxidative injury via regulating the mitochondrial apoptosis pathway. Cell Mol Neurobiol. 2020;40:1231–1242. doi:10.1007/s10571-020-00817-2
   PubMed Web of Science ®Google Scholar
• Zhou YL, Wu WP, Cheng J, et al. CircFOXO3 rs12196996, a polymorphism at the gene flanking intron, is associated with circFOXO3 levels and the risk of coronary artery disease. Aging. 2020;12:13076–13089. doi:10.18632/aging.103398
   PubMedGoogle Scholar
• Qiu Y, Xie X, Lin L. circFOXO3 protects cardiomyocytes against radiation induced cardiotoxicity. Mol Med Rep. 2021;23:1.
   Web of Science ®Google Scholar
• Ren X, Yu J, Guo L, Ma H. Circular RNA circRHOT1 contributes to pathogenesis of non-small cell lung cancer by epigenetically enhancing C-MYC expression through recruiting KAT5. Aging. 2021;13:20372–20382. doi:10.18632/aging.203417
   PubMedGoogle Scholar
• Cai L, Qi B, Wu X, et al. Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b. J Mol Cell Cardiol. 2019;130:10–22. doi:10.1016/j.yjmcc.2019.03.007
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang Z, Cheng Q, et al. Circular RNA (circRNA) CDYL induces myocardial regeneration by ceRNA after myocardial infarction. Med Sci Monit. 2020;26:e923188.
   PubMed Web of Science ®Google Scholar
• Andersson U, Yang H, Harris H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets. 2018;22:263–277. doi:10.1080/14728222.2018.1439924
   PubMed Web of Science ®Google Scholar
• Vijayakumar EC, Bhatt LK, Prabhavalkar KS. High Mobility Group Box-1 (HMGB1): a potential target in therapeutics. Curr Drug Targets. 2019;20:1474–1485. doi:10.2174/1389450120666190618125100
   PubMed Web of Science ®Google Scholar
• Liu FY, Fan D, Yang Z, et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 2019;10:480. doi:10.1038/s41419-019-1718-7
   PubMed Web of Science ®Google Scholar
• Deng M, Tang Y, Li W, et al. The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity. 2018;49:740–753 e7. doi:10.1016/j.immuni.2018.08.016
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116:353–367. doi:10.1093/cvr/cvz139
   PubMed Web of Science ®Google Scholar
• Zhou LY, Zhai M, Huang Y, et al. The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway. Cell Death Differ. 2019;26:1299–1315. doi:10.1038/s41418-018-0206-4
   PubMed Web of Science ®Google Scholar
• Liu R, Li Z, Wang Q. Resolvin D1 attenuates myocardial infarction in a rodent model with the participation of the HMGB1 pathway. Cardiovasc Drugs Ther. 2019;33:399–406. doi:10.1007/s10557-019-06884-y
   PubMed Web of Science ®Google Scholar
• Bauza MDR, Gimenez CS, Locatelli P, et al. High-dose intramyocardial HMGB1 induces long-term cardioprotection in sheep with myocardial infarction. Drug Deliv Transl Res. 2019;9:935–944. doi:10.1007/s13346-019-00628-z
   PubMed Web of Science ®Google Scholar